{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:05:41Z","timestamp":1787501141719,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001923","name":"Health Services Research Programme","doi-asserted-by":"publisher","award":["HPRU-2012-10047"],"award-info":[{"award-number":["HPRU-2012-10047"]}],"id":[{"id":"10.13039\/501100001923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Antimicrob Resist Infect Control"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In order to change antibiotic prescribing behaviour, we need to understand the prescribing process. The aim of this study was to identify targets for antibiotic stewardship interventions in hospitals through analysis of the antibiotic prescribing process from admission to discharge across five groups of infectious diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multi-centre, observational cohort study, including patients with lower respiratory tract infections, exacerbation of chronic obstructive pulmonary disease, skin- and soft tissue infections, urinary tract infections or sepsis, admitted to wards of infectious diseases, pulmonary medicine and gastroenterology at three teaching hospitals in Western Norway. Data was collected over a 5-month period and included antibiotics prescribed and administered during admission, antibiotics prescribed at discharge, length of antibiotic therapy, indication for treatment and discharge diagnoses, estimated glomerular filtration rate (eGFR) on admission, antibiotic allergies, place of initiation of therapy, admittance from an institution, patient demographics and outcome data. Primary outcome measure was antibiotic use throughout the hospital stay, analysed by WHO AWaRe-categories and adherence to guideline. Secondary outcome measures were a) antibiotic prescribing patterns by groups of diagnoses, which were analysed using descriptive statistics and b) non-adherence to the national antibiotic guidelines, analysed using multivariate logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Through analysis of 1235 patient admissions, we identified five key targets for antibiotic stewardship interventions in our population of hospital inpatients; 1) adherence to guideline on initiation of treatment, as this increases the use of WHO Access-group antibiotics, 2) antibiotic prescribing in the emergency room (ER), as 83.6% of antibiotic therapy was initiated there, 3) understanding prescribing for patients admitted from other institutions, as this was significantly associated with non-adherence to guideline (OR\u2009=\u20091.44 95% CI 1.04, 2.00), 4) understanding cultural and contextual drives of antibiotic prescribing, as non-adherent prescribing differed significantly between the sites of initiation of therapy (between hospitals and ER versus ward) and 5) length of therapy, as days of antibiotic therapy was similar across a wide range of diagnoses and with prolonged therapy after discharge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Analysing the process of antibiotic prescribing in hospitals with patient-level data identified important targets for antibiotic stewardship interventions in hospitals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13756-020-00749-y","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T16:02:47Z","timestamp":1595347367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identifying targets for antibiotic stewardship interventions through analysis of the antibiotic prescribing process in hospitals - a multicentre observational cohort study"],"prefix":"10.1186","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0828-2909","authenticated-orcid":false,"given":"Jannicke Slettli","family":"Wathne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brita","family":"Skodvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmita","family":"Charani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stig","family":"Harthug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege Salvesen","family":"Blix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy M.","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars K\u00e5re Selland","family":"Kleppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vukovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"issue":"3","key":"749_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3201\/eid0803.010192","volume":"8","author":"SL Bronzwaer","year":"2002","unstructured":"Bronzwaer SL, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, et al. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis. 2002;8(3):278\u201382.","journal-title":"Emerg Infect Dis"},{"key":"749_CR2","unstructured":"European Centre for Disease Prevention and Control. Antimicrobial consumption. Annual Epidemiological Report for 2017. Stockholm: ECDC 2018. https:\/\/ecdc.europa.eu\/sites\/portal\/files\/documents\/AER_for_2017-antimicrobial-consumption.pdf. Accessed 20 Apr 2019."},{"issue":"12","key":"749_CR3","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1093\/jac\/dkt268","volume":"68","author":"JB Haug","year":"2013","unstructured":"Haug JB, Reikvam A. WHO defined daily doses versus hospital-adjusted defined daily doses: impact on results of antibiotic use surveillance. J Antimicrob Chemother. 2013;68(12):2940\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR4","unstructured":"NORM\/NORM-VET. Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway 2017. Tromso\/Oslo: Norwegian Surveillance System for Antibiotic Resistance in Microbes (NORM), Norwegian Veterinary Institute, Norwegian Institute of Public Health; 2018. https:\/\/unn.no\/Documents\/Kompetansetjenester,%20-sentre%20og%20fagr%C3%A5d\/NORM%20-%20Norsk%20overv%C3%A5kingssystem%20for%20antibiotikaresistens%20hos%20mikrober\/Rapporter\/NORM_NORM-VET_2017.pdf. Accessed 26 Sep 2018."},{"issue":"6","key":"749_CR5","doi-asserted-by":"publisher","first-page":"561.e7","DOI":"10.1016\/j.cmi.2016.01.026","volume":"22","author":"R Bitterman","year":"2016","unstructured":"Bitterman R, Hussein K, Leibovici L, Carmeli Y, Paul M. Systematic review of antibiotic consumption in acute care hospitals. Clin Microbiol Infect. 2016;22(6):561.e7\u2013e19.","journal-title":"Clin Microbiol Infect"},{"key":"749_CR6","doi-asserted-by":"publisher","unstructured":"Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Systematic Reviews. 2017. https:\/\/doi.org\/10.1002\/14651858.CD003543.pub4:(2.","DOI":"10.1002\/14651858.CD003543.pub4:(2"},{"issue":"2","key":"749_CR7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1365-2125.2010.03840.x","volume":"71","author":"MA Aldeyab","year":"2011","unstructured":"Aldeyab MA, Kearney MP, McElnay JC, Magee FA, Conlon G, Gill D, et al. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol. 2011;71(2):293\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"749_CR8","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1093\/jac\/dkx243","volume":"72","author":"P Howard","year":"2017","unstructured":"Howard P, Huttner B, Beovic B, Beraud G, Kofteridis DP, Pano Pardo J, et al. ESGAP inventory of target indicators assessing antibiotic prescriptions: a cross-sectional survey. J Antimicrob Chemother. 2017;72(10):2910\u20134.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"749_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S1473-3099(17)30724-7","volume":"18","author":"M Sharland","year":"2018","unstructured":"Sharland M, Pulcini C, Harbarth S, Zeng M, Gandra S, Mathur S, et al. Classifying antibiotics in the WHO essential medicines list for optimal use-be AWaRe. Lancet Infect Dis. 2018;18(1):18\u201320.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"749_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1473-3099(18)30547-4","volume":"19","author":"Y Hsia","year":"2019","unstructured":"Hsia Y, Sharland M, Jackson C, Wong ICK, Magrini N, Bielicki JA. Consumption of oral antibiotic formulations for young children according to the WHO access, watch, reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries. Lancet Infect Dis. 2019;19(1):67\u201375.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"749_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13756-018-0400-7","volume":"7","author":"JS Wathne","year":"2018","unstructured":"Wathne JS, Kleppe LKS, Harthug S, Blix HS, Nilsen RM, Charani E, et al. The effect of antibiotic stewardship interventions with stakeholder involvement in hospital settings: a multicentre, cluster randomized controlled intervention study. Antimicrobial Resistance Infection Control. 2018;7(1):109.","journal-title":"Antimicrobial Resistance Infection Control"},{"key":"749_CR12","unstructured":"Norwegian Directorate of Health. Norwegian National Clinical Guideline for Antibiotic Use in Hospitals. 2013. https:\/\/helsedirektoratet.no\/retningslinjer\/antibiotika-i-sykehus. Accessed 3 Jan 2016."},{"issue":"5","key":"749_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"key":"749_CR14","unstructured":"Stagg V. Charlson: Stata module to calculate Charlson index of comorbidity. Orebro University School of Business 2017. https:\/\/econpapers.repec.org\/software\/bocbocode\/s456719.htm. Accessed 06 Dec 2018."},{"key":"749_CR15","unstructured":"World Health Organization (WHO). WHO Model List of Essential Medicines. 2017. http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/20th_EML2017_FINAL_amendedAug2017.pdf?ua=1. Accessed 2 Aug 2018."},{"issue":"12","key":"749_CR16","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/S1473-3099(14)70952-1","volume":"14","author":"NP Braykov","year":"2014","unstructured":"Braykov NP, Morgan DJ, Schweizer ML, Uslan DZ, Kelesidis T, Weisenberg SA, et al. Assessment of empirical antibiotic therapy optimisation in six hospitals: an observational cohort study. Lancet Infect Dis. 2014;14(12):1220\u20137.","journal-title":"Lancet Infect Dis"},{"key":"749_CR17","doi-asserted-by":"crossref","unstructured":"Tamma PD, Miller MA, Cosgrove SE. Rethinking How Antibiotics Are Prescribed: Incorporating the 4 Moments of Antibiotic Decision Making Into Clinical Practice. JAMA. 2019;321(2):139\u201340.","DOI":"10.1001\/jama.2018.19509"},{"key":"749_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13756-015-0065-4","volume":"4","author":"B Skodvin","year":"2015","unstructured":"Skodvin B, Aase K, Charani E, Holmes A, Smith I. An antimicrobial stewardship program initiative: a qualitative study on prescribing practices among hospital doctors. Antimicrob Resist Infect Control. 2015;4:24.","journal-title":"Antimicrob Resist Infect Control"},{"key":"749_CR19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13756-019-0480-z","volume":"8","author":"B Skodvin","year":"2019","unstructured":"Skodvin B, Wathne JS, Lindemann PC, Harthug S, Nilsen RM, Charani E, et al. Use of microbiology tests in the era of increasing AMR rates- a multicentre hospital cohort study. Antimicrob Resist Infect Control. 2019;8:28.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"749_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1093\/cid\/ciy844","volume":"69","author":"E Charani","year":"2019","unstructured":"Charani E, Ahmad R, Rawson TM, Castro-Sanchez E, Tarrant C, Holmes AH. The differences in antibiotic decision-making between acute surgical and acute medical teams: an ethnographic study of culture and team dynamics. Clin Infect Dis. 2019;69(1):12\u201320. https:\/\/doi.org\/10.1093\/cid\/ciy844.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"749_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/intqhc\/mzu091","volume":"27","author":"N Ukawa","year":"2015","unstructured":"Ukawa N, Tanaka M, Morishima T, Imanaka Y. Organizational culture affecting quality of care: guideline adherence in perioperative antibiotic use. Int J Qual Health Care. 2015;27(1):37\u201345.","journal-title":"Int J Qual Health Care"},{"issue":"2","key":"749_CR22","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1093\/cid\/cit212","volume":"57","author":"E Charani","year":"2013","unstructured":"Charani E, Castro-Sanchez E, Sevdalis N, Kyratsis Y, Drumright L, Shah N, et al. Understanding the determinants of antimicrobial prescribing within hospitals: the role of \u201cprescribing etiquette\u201d. Clin Infect Dis. 2013;57(2):188\u201396.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"749_CR23","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/jac\/dkw441","volume":"72","author":"D Viasus","year":"2017","unstructured":"Viasus D, Simonetti AF, Garcia-Vidal C, Niubo J, Dorca J, Carratala J. Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia. J Antimicrob Chemother. 2017;72(2):547\u201353.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"749_CR24","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10096-017-3136-z","volume":"37","author":"C Aillet","year":"2018","unstructured":"Aillet C, Jammes D, Fribourg A, Leotard S, Pellat O, Etienne P, et al. Bacteraemia in emergency departments: effective antibiotic reassessment is associated with a better outcome. Eur J Clin Microbiol Infect Dis. 2018;37(2):325\u201331.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"749_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/jac\/dkq018","volume":"65","author":"P Lesprit","year":"2010","unstructured":"Lesprit P, Landelle C, Girou E, Brun-Buisson C. Reassessment of intravenous antibiotic therapy using a reminder or direct counselling. J Antimicrob Chemother. 2010;65(4):789\u201395.","journal-title":"J Antimicrob Chemother"},{"key":"749_CR26","unstructured":"Public Health England. Start Smart - Then Focus. Antimicrobial Stewardship Toolkit for English Hospitals. London: Public Health England. 2015. https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/417032\/Start_Smart_Then_Focus_FINAL.PDF. Accessed 9 June 2019."},{"key":"749_CR27","unstructured":"Centers for Disease Control and Prevention (CDC). Core Elements of Hospital Antibiotic Stewardship Programs. Atlanta: US Department of Health and Human Services, CDC. 2014. https:\/\/www.cdc.gov\/antibiotic-use\/healthcare\/pdfs\/core-elements.pdf. Accessed 9 June 2019."},{"key":"749_CR28","unstructured":"Norwegian Department of Health and Care Services. Action plan against antibiotic resistance in health services. Oslo; 2015. https:\/\/www.regjeringen.no\/contentassets\/915655269bc04a47928fce917e4b25f5\/handlingsplan-antibiotikaresistens.pdf. Accessed 21 Mar 2016."},{"key":"749_CR29","doi-asserted-by":"publisher","first-page":"j3418","DOI":"10.1136\/bmj.j3418","volume":"358","author":"MJ Llewelyn","year":"2017","unstructured":"Llewelyn MJ, Fitzpatrick JM, Darwin E, SarahTonkin-Crine GC, Paul J, et al. The antibiotic course has had its day. Bri Med J. 2017;358:j3418.","journal-title":"Bri Med J"},{"issue":"9","key":"749_CR30","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamainternmed.2016.3646","volume":"176","author":"B Spellberg","year":"2016","unstructured":"Spellberg B. The new antibiotic mantra\u2014\u201cshorter is better\u201deditorial. JAMA Intern Med. 2016;176(9):1254\u20135.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"749_CR31","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","volume":"176","author":"A Uranga","year":"2016","unstructured":"Uranga A, Espana PP, Bilbao A, Quintana JM, Arriaga I, Intxausti M, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016;176(9):1257\u201365.","journal-title":"JAMA Intern Med"},{"issue":"7","key":"749_CR32","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/cid\/ciy1054","volume":"69","author":"D Yahav","year":"2019","unstructured":"Yahav D, Franceschini E, Koppel F, Turjeman A, Babich T, Bitterman R, et al. Seven versus fourteen days of antibiotic therapy for uncomplicated gram-negative bacteremia: a non-inferiority randomized controlled trial. Clin Infect Dis. 2019;69(7):1091\u20138. https:\/\/doi.org\/10.1093\/cid\/ciy1054.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"749_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/fampra\/cmx037","volume":"34","author":"EE Dawson-Hahn","year":"2017","unstructured":"Dawson-Hahn EE, Mickan S, Onakpoya I, Roberts N, Kronman M, Butler CC, et al. Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews. Fam Pract. 2017;34(5):511\u20139.","journal-title":"Fam Pract"},{"issue":"20","key":"749_CR34","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191\u20134.","journal-title":"JAMA."}],"container-title":["Antimicrobial Resistance &amp; Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00749-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13756-020-00749-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13756-020-00749-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T19:14:13Z","timestamp":1626808453000},"score":1,"resource":{"primary":{"URL":"https:\/\/aricjournal.biomedcentral.com\/articles\/10.1186\/s13756-020-00749-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1186\/s13756-020-00749-y","relation":{},"ISSN":["2047-2994"],"issn-type":[{"value":"2047-2994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"16 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Declaration of Helsinki [\n                      \n                      ]. The study was approved by the local data protection officer (2013\/9352) and the regional ethical committee of Western Norway approved the waiver of informed consent (2013\/1305). All patients treated with antibiotics received an information leaflet at the ward about the study and provided the opportunity to withdraw from the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"114"}}